Original Scientific Article
Canine mammary tumours - Clinical survey
Elena Atanaskova Petrov * ,
Ksenija Ilievska ,
Plamen Trojacanec ,
Irena Celeska ,
Goran Nikolovski ,
Ivica Gjurovski ,
Toni Dovenski

Mac Vet Rev 2014; 37 (2): 129 - 134

10.14432/j.macvetrev.2014.05.015

Received: 26 February 2014

Received in revised form: 02 April 2014

Accepted: 12 May 2014

Available Online First: 16 May 2014

Published on: 15 October 2014

Correspondence: Elena Atanaskova Petrov, dovenski@fvm.ukim.edu.mk
PDF HTML

Abstract

Mammary tumours are the second most frequent neoplasia in dogs, mainly affecting older female patients. Approximately 50% of the mammary tumours are malignant with high percentage of mortality if not treated in time. The aim of this study was to analyze the data of canine patients with mammary tumours, to evaluate the type of tumours, as well as the relationship between tumour incidence and dogs’ age, reproductive cycle and sterilization. The survey was used to retrieve the information in the period of two years from the patient data base of the University Veterinary Hospital at the Faculty of Veterinary medicine in Skopje.Patients included in this survey were subjected to routine clinical investigation and additional laboratory tests (cytological examination, x-rays imaging, CBC and biochemical profi le, histopathology of the tumor samples). Aged female patients (12 – 13 years) are the most susceptible category for development of mammary tumours. The reproductive history showed that fi ve of the patients with malignant mammary tumourshave never whelped and were not treated with any exogenous hormones. Malignant tumours (adenocarcinoma) were diagnosed in 90% of the patients. Three patients died due to lung metastasis. Late diagnosis is one of the major problems that results in lethal outcome due to lung metastases. Since ovarian steroids play an important role in the aetiology, the most effective prevention of mammary tumoursis elective ovariectomy of the bitch at an early age.

Keywords: mammary tumours, bitches, cytology, histopathology


References

1. Moulton, J.E. (1990). Tumours of the mammary gland. In Moulton J.E. (Ed.), Tumours in Domestic Animals, (pp 518–552). Berkeley: University of California Press.
2. Sorenmo K. (2003). Canine mammary gland tumors. Vet Clin North Am Small Anim Pract. 33, 573–596. http://dx.doi.org/10.1016/S0195-5616(03)00020-2
3. Perez, A., Pena, L., Del Castillo, N., Nieto A.I. (2000). Factors influencing the incidence and prognosis of canine mammary tumours. J Small Anim Pract. 41, 287–291.
http://dx.doi.org/10.1111/j.1748-5827.2000.tb03203.x
4. Sorenmo, K.U., Kristiansen, V.M., Cofone, M.A., Shofer, F.S., Breen, A.M., Langeland, M., Mongil, C.M., Grondahl, A.M., Teige, J., Goldschmidt, M.H. (2009). Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol. 7, 162–172. http://dx.doi.org/10.1111/j.1476-5829.2009.00184.x PMid:19691645
5. Rutteman, G. R. (1990). Hormones and mammary tumour disease in the female dog: an update. In vivo. 4, 33–40. PMid:2103839
6. Misdorp, W. (2002). Tumours of the mammary gland. In: Meuten D.J. (Ed.), Tumours in Domestic Animals, (pp. 575–606). Ames: Iowa State Press.
http://dx.doi.org/10.1002/9780470376928.ch12
7. MacEwen, E.G., Withrow, S. (1996). Tumours of the mammary gland. Small Animal Oncology. (pp. 356–372) Philadelphia: Saunders Company.
8. Lana, S.E., Rutteman, G.R., Withrow, S.J. (2007). Tumours of the mammary gland. In: Withrow S.J. & MacEwen B.R. (Ed.), Small Animal Clinical Oncology, (pp 455-477). Philadelphia: Saunders Company. http://dx.doi.org/10.1016/B978-072160558-6.50029-0
9. Murphy, S. (2008). Mammary tumours in dogs and cats. In practice. 6, 334–339. http://dx.doi.org/10.1136/inpract.30.6.334
10. Withrow, S. J.,Vail, D. M. (2007). Small animal clinical oncology. Fourth edition, (pp 619–636). Saunders Elsevier.
11. Misdorp, W., Hellmen, E., Else, R.W. (1999). Mammary Tumours and dysplasia in dogs and cats.Histologic classification of tumours of domestic animals. Second series (pp 3-6). Washington, DC: Armed Forces Institute of Pathology.
12. Zatloukal, J., Lorenzová, J., Tichy, F., Nečas, A., Kecová, H., Kohout, P. (2005). Breed and age as risk factors for canine mammary tumours. Acto Vet Brno. 74, 103–109.
http://dx.doi.org/10.2754/avb200574010103
13. Sorenmo, K.U., Shoferm, F.S., Goldschmidt, M.H. (2000). Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med. 14, 266–270. http://dx.doi.org/10.1111/j.1939-1676.2000.tb01165.x PMid:10830539
14. Queiroga, F.L., Perez- Alenza, M.D., Silvan, G., Pena, L., Lopes, C., Illera, J.C. (2005). Role of steroid hormones and prolactin in canine mammary cancer. J Steroid Biochem Mol Biol. 94, 181–187. http://dx.doi.org/10.1016/j.jsbmb.2004.12.014 PMid:15862964
15. Schneider, R., Dorn, C.R., Taylor, D.O. (1969). Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst. 43, 1249–1261. PMid:4319248
16. Stovring, M., Moe, L., Glattre, E. (1997). A population- based case-control study of canine mammary tumours and clinical use of medroxyprogesterone acetate. APMIS. 105, 590–596. http://dx.doi.org/10.1111/j.1699-0463.1997.tb05057.x PMid:9298095
17. Chang, S.C., Chang, C.C., Chang, T.J., Wong, M.L. (2005). Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumours: 79 cases (1998-2002). J Am Vet Med Assoc. 227, 1625-1629. http://dx.doi.org/10.2460/javma.2005.227.1625 PMid:16313041
18. Sontasa, B.H., Ozyogurtcub, H., Gurelb, A., Ekicia, H. (2009). Evaluation of clinical and pathological characteristics of 155 canines with mammary tumours: a retrospective study. Arch Med Vet. 41, 53-59.
19. Benjamin, S.A., Lee, A.C., Saunders, W.J. (1999). Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles. Vet Pathol. 36, 423–436. http://dx.doi.org/10.1354/vp.36-5-423 PMid:10490210
20. Ežerskytė, A., Zamokas, G., Grigonis, A., Juodžiukynienė, N. (2011). The retrospective analyses of mammary tumours in dogs. ISSN 1392-2130. Vet Med Zoot. 53 (75), 3-8.
21. Fossum, T.W., Hedlund, C.S. (1997). Mammary neoplasia. In Duncan L. (Ed.), Small Animal Surgey (pp. 539–544). St-Louis: Don Ladig.
22. Straw, R.C. (2005). Treatment of mammary gland tumours and perianal neoplasia. The North American Veterinary Conference (NAVC). Orlando, Florida. http://aleksabokarev.narod.ru/foreignarticle/14.pdf
23. Moe, L. (2001). Population-based incidence of mammary tumours in some dog breeds. J Reprod Fertil Suppl. 57, 439-43. PMid:11787188
24. Stratmann, N., Failing, K., Richter, A., Wehrend, A. (2008). Mammary tumour recurrence in bitches after regional mastectomy. Vet Surg. 37, 82–86.
http://dx.doi.org/10.1111/j.1532-950X.2007.00351.x PMid:18199060
25. Sleeckx, N., de Rooster, H., Veldhuis Kroeze, E.J.B., Van Ginneken, C., Van Brantegem, L. (2011). Canine mammary tumours, an overview. Reprod Dom Anim. 46, 1112–1131. http://dx.doi.org/10.1111/j.1439-0531.2011.01816.x


Copyright

© 2014 Atanaskova Petrov E. This is an open-access article published under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Conflict of Interest Statement

The authors declared that they have no potential conflict of interest with respect to the authorship and/or publication of this article.

Citation Information

Macedonian Veterinary Review. Volume 37, Issue 2, Pages 129-134, p-ISSN 1409-7621, e-ISSN 1857-7415, DOI: 10.14432/j.macvetrev.2014.05.015, 2014